| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| The development of personalized cancer therapies, particularly through mRNA technology, marks a significant advancement in healthcare and product development. Merck's strong drug pipeline and successful partnerships, such as with Moderna, are enhancing investor confidence and positioning the company as a leader in cancer treatment innovation. However, challenges remain as evidenced by negative clinical trial outcomes in related studies, which could impact future development efforts. Overall, the trend towards personalized medicine is driving positive momentum despite some setbacks. |
| The price action of MERCK & CO. INC. (MRK) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 3.4 is extremely bullish. The market sentiment at 1.5 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. MRK is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 2, and the negative at -0.5 on 2026-08-20. The forces of Sentiment towards Fundamentals (3.6), Stock Price Trend (3.4), Market Risk Appetite (3), Option Sentiment (1.5), and Sector Price Trend (1.1) will drive up the price. The forces of Price Level Sentiment (-1), and Valuation Sentiment (-1.7) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRK | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | 1%(0.3%) | 149.2 | 4.29% | 112 | 79 | 55 | -2% | 1.56% | 3.4 | -0.1 | 4.4% | 1.6 | Wait | 50% | 3.6 | -1.8 |
| 2026-08-19 | 1%(0.1%) | 152.24 | 3.46% | 145 | 88 | 87 | 12.63% | 1.82% | 4.2 | 2.2 | 4.5% | 1.4 | Wait | 50% | 2.8 | 5 |
| 2026-08-18 | 0%(0%) | 135.17 | 1.99% | 89 | 68 | 41 | -0.59% | 0.53% | 1.2 | -0.2 | 0.4% | 0 | Wait | 50% | 0.8 | -1 |
| 2026-08-17 | 0%(0%) | 135.97 | 1.99% | 100 | 65 | 56 | 0.08% | 0.61% | 1.5 | 0 | 0.5% | 0.3 | Long | 70% | 0.7 | -1 |
| 2026-08-16 | 0%(0%) | 1.4 | 0 | 0.3 | 1.1 | -1 | ||||||||||
| 2026-08-15 | 0%(0%) | 1.4 | 0 | 0.3 | 1.1 | -1 | ||||||||||
| 2026-08-14 | 0%(0%) | 135.86 | 2% | 104 | 67 | 61 | 0.23% | 0.46% | 1.4 | 0.4 | 0.6% | 0.3 | Wait | 50% | 1.1 | -1 |
| 2026-08-13 | 0%(0%) | 135.55 | 1.78% | 112 | 65 | 74 | 1.96% | 0.46% | 1.4 | 0.4 | 1.3% | 0.2 | Wait | 50% | 1.1 | -1 |
| 2026-08-12 | 0%(0%) | 132.94 | 1.51% | 97 | 60 | 69 | 1.91% | 0.15% | 1 | 0.2 | 1% | 0.5 | Wait | 50% | 2.5 | -1 |
| 2026-08-11 | 0%(0%) | 130.45 | 1.66% | 70 | 61 | 63 | -0.34% | -0.08% | 0.5 | 0.2 | 0.7% | 0.7 | Long | 55% | 3.2 | -1 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-08-20 17:48:45 The article highlights Merck's success with its cancer vaccine, Keytruda, indicating a strong product development achievement. |
| 2026-08-20 17:48:45 The article discusses a downgrade in Merck's stock by RBC Capital Markets despite a recent rally, indicating concerns about future performance. |
| 2026-08-20 17:25:46 The impact of positive clinical trial outcomes for cancer therapies on market behavior and investor confidence in pharmaceutical stocks. |
| 2026-08-20 17:25:46 The growing investor interest in mRNA technology, driven by the success of the COVID-19 vaccine and now its application in oncology. |
| 2026-08-20 17:25:46 The varying perspectives from analysts regarding the potential of Merck and Moderna stocks following their recent breakthroughs, influencing investor sentiment and stock valuation. |
| 2026-08-20 17:25:46 The fluctuating stock prices of Moderna and Merck, marked by sharp rises and falls in response to news about clinical trials and market reactions. |
| 2026-08-20 17:25:46 The significant advancements made by Merck and Moderna in developing personalized mRNA cancer vaccines, which have the potential to pave the way for new treatments against various tumors. |
| 2026-08-20 15:53:10 The articles highlight the recent success of Merck's cancer vaccine, Keytruda, which represents a significant achievement for the company. |
| 2026-08-20 15:53:10 The downgrade by RBC Capital Markets reflects a cautious outlook from analysts concerning the company's future stock performance. |
| 2026-08-20 15:53:10 The articles discuss the downgrade of Merck's stock despite recent positive developments in its product offerings, indicating concern among analysts. |
| 2026-08-20 13:49:59 The market's response to the downgrade indicates a cautious view on stock valuation despite positive news about product development. |
| 2026-08-20 13:49:59 Merck's achievement in cancer vaccine development is a significant milestone that positively influences its market perception. |
| 2026-08-20 13:49:59 The downgrade of Merck's stock following a rally reflects analysts' concerns about future performance despite recent successes. |
| 2026-08-20 09:35:56 Morgan Stanley's buy rating for Merck suggests optimism about the company's future performance. |
| 2026-08-20 09:35:56 The upcoming patent expiration of Keytruda raises concerns about revenue declines for Merck. |
| 2026-08-20 09:35:56 Merck is developing promising drugs that are close to market, which boosts investor confidence. |